* Artivion Inc AORT.N reported a quarterly adjusted loss
of 10
cents per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of 5
cents. The mean expectation of five analysts for the quarter
was for a loss of 10 cents per share. Wall Street expected
results to range from -22 cents to -4 cents per share.
* Revenue rose 18% to $93.67 million from a year ago;
analysts
expected $89.29 million.
* Artivion Inc's reported EPS for the quarter was a loss
of 10
cents.
* The company reported a quarterly loss of $3.98 million.
* Artivion Inc shares had fallen by 1.8% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 22.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "strong buy"
Wall Street's median 12-month price target for Artivion Inc is
$25.00
This summary was machine generated from LSEG data February 15 at
10:44 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.10 -0.10 Met
Sep. 30 2023 -0.06 -0.24 Missed
Jun. 30 2023 -0.08 -0.07 Beat
Mar. 31 2023 -0.14 -0.33 Missed